Glaxosmithkline S.a.e.EGX: BIOC

Glaxosmithkline Q3 Consol Loss EGP 34.8 Million

· Issued by Glaxosmithkline S.a.e.

GLAXOSMITHKLINE SAE EGX:BIOC:

  • GLAXOSMITHKLINE Q3 CONSOL NET LOSS ATTRIBUTABLE EGP 34.8 MILLION

  • GLAXOSMITHKLINE Q3 CONSOL NET SALES EGP 1.01 BILLION